Chisa Kondo

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study

Masanori Atsukawa, Akihito Tsubota, Hidenori Toyoda et al. · Alimentary Pharmacology & Therapeutics · 2019 · 50 citations

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

Taeang Arai, Masanori Atsukawa, Akihito Tsubota et al. · Hepatology Communications · 2022 · 49 citations · Full text

Pathology, Pharmacotherapy, Fatty Liver Disease +20

Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C

Masanori Atsukawa, Akihito Tsubota, Yohei Koushima et al. · Hepatology Research · 2017 · 45 citations

Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease

Taeang Arai, Masanori Atsukawa, Akihito Tsubota et al. · Digestive and Liver Disease · 2019 · 45 citations

Nutrition, Metabolic Syndrome, Liver Fibrosis +14

Relationship between serum vitamin D level and sarcopenia in chronic liver disease

Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota et al. · Hepatology Research · 2020 · 34 citations